Wenzhou Central Hospital
Wenzhou Central Hospital
Explore linked clinical trials.10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PROfunda Femoris Vein Thrombosis Evaluation and Clearance to Improve Outcomes of Endovascular Treatment for Acute Iliofemoral Deep Vein Thrombosis | Deep Vein Thrombosis, Embolism and Thrombosis, Postthrombotic Syndrome, Venous Thrombosis, cardiovascular disorder, thrombotic disease, vascular disorder, venous insufficiency | Recruiting | Not applicable | 2026-09-02 | NCT07622199 | |
| The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution Time | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Nutritional and Metabolic Diseases, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Not yet recruiting | Phase 4 | 2026-06-22 | NCT07661030 | |
| Comparison Of Different Mechanical Thrombectomy Devices in Endovascular Treatment of Acute Iliofemoral Venous Thrombosis | Deep Vein Thrombosis, Embolism and Thrombosis, Postthrombotic Syndrome, Venous Thrombosis, cardiovascular disorder, thrombotic disease, vascular disorder, venous insufficiency | Recruiting | Not stated | 2026-06-03 | NCT07622212 | |
| Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma | Primary Central Nervous System Hodgkin Lymphoma | Recruiting | Phase 2 | 2025-07-31 | NCT04961515 | |
| Explainable Machine Learning for Predicting Early Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, microinvasive gastric cancer, neoplasm, stomach disorder | Enrolling by invitation | Not stated | 2025-07-02 | NCT07047937 | |
| a Single Arm, Phase II Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of Iparomlimab and Tuvonralima b and Chemotherapy ± Bevacizumab Induction Therapy Followed by Concurrent Chemoradiotherapy in Patients With Advanced Cervical Cancer . | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Not yet recruiting | Phase 2 | 2025-06-25 | NCT07035808 | |
| Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs) | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 4 | 2025-06-15 | NCT04624295 | |
| Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, digestive system disorder, digestive system neoplasm, disease, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Not stated | 2025-06-04 | NCT06078930 | |
| A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus | Type 2 Diabetic Patients | Enrolling by invitation | Phase 4 | 2025-04-13 | NCT06925334 | |
| Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label Trial | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Not applicable | 2025-03-07 | NCT06863532 |